{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T09:36:49Z","timestamp":1771753009815,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Society of Hypertension"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.jash.2007.08.004","type":"journal-article","created":{"date-parts":[[2008,1,18]],"date-time":"2008-01-18T07:35:45Z","timestamp":1200641745000},"page":"20-27","source":"Crossref","is-referenced-by-count":8,"title":["Effects of the hormone therapy, drospirenone and 17-beta estradiol, on early morning blood pressure in postmenopausal women with hypertension"],"prefix":"10.1016","volume":"2","author":[{"given":"William B.","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Hanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhavi","family":"Mallareddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jash.2007.08.004_bib1","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1056\/NEJM200008243430801","article-title":"Effects of estrogen replacement on the progression of coronary-artery atherosclerosis","volume":"343","author":"Herrington","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2007.08.004_bib2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2007.08.004_bib3","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa010534","article-title":"A clinical trial of estrogen-replacement therapy after ischemic stroke","volume":"345","author":"Viscoli","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2007.08.004_bib4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa030830","article-title":"Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women","volume":"349","author":"Hodis","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2007.08.004_bib5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease","volume":"349","author":"Manson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2007.08.004_bib6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11906-000-0017-z","article-title":"Aldosterone and vascular damage","volume":"2","author":"Duprez","year":"2000","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jash.2007.08.004_bib7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats","volume":"31","author":"Rocha","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2007.08.004_bib8","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","article-title":"Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure","volume":"101","author":"Farquharson","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2007.08.004_bib9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJM200109203451215","article-title":"Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease","volume":"345","author":"Chrysostomou","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2007.08.004_bib10","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/01.HYP.0000067463.13172.EA","article-title":"Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension","volume":"41","author":"White","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2007.08.004_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9149(03)00461-2","article-title":"Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension","volume":"92","author":"White","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jash.2007.08.004_bib12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2007.08.004_bib13","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2007.08.004_bib14","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1210\/jc.80.6.1816","article-title":"Effects of a new oral contraceptive containing an anti-mineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism","volume":"80","author":"Oelkers","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jash.2007.08.004_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.jash.2007.08.004_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0039-128X(96)00007-4","article-title":"Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure","volume":"61","author":"Oelkers","year":"1996","journal-title":"Steroids"},{"key":"10.1016\/j.jash.2007.08.004_bib17","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0895-7061(02)02980-1","article-title":"Additive effect of Drospirenone\/17-beta estradiol in hypertensive postmenopausal women receiving enalapril","volume":"15","author":"Preston","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2007.08.004_bib18","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.104.501502","article-title":"Antihypertensive effects of drospirenone with 17\u03b2-estradiol, a novel hormone treatment in postmenopausal women with Stage 1 hypertension","volume":"112","author":"White","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2007.08.004_bib19","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.HYP.0000232179.60442.84","article-title":"Effects of a new hormone therapy, drospirenone and 17-beta-estradiol, in postmenopausal women with hypertension","volume":"48","author":"White","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2007.08.004_bib20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/01.gme.0000177318.24005.b1","article-title":"Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial","volume":"12","author":"Archer","year":"2005","journal-title":"Menopause"},{"key":"10.1016\/j.jash.2007.08.004_bib21","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.amjhyper.2004.12.003","article-title":"Effects of drospirenone\/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women","volume":"18","author":"Preston","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2007.08.004_bib22","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa003417","article-title":"Impact of high-normal blood pressure on the risk of cardiovascular disease","volume":"345","author":"Vasan","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2007.08.004_bib23","series-title":"Blood pressure monitoring in cardiovascular medicine and therapeutics","first-page":"273","article-title":"Advances in ambulatory blood pressure monitoring for the evaluation of antihypertensive therapy in research and practice","author":"White","year":"2000"},{"key":"10.1016\/j.jash.2007.08.004_bib24","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ahj.2004.07.008","article-title":"Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product","volume":"148","author":"White","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jash.2007.08.004_bib25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0002-8703(02)00137-0","article-title":"Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising","volume":"144","author":"White","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.jash.2007.08.004_bib26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF00265917","article-title":"Comparison of casual, ambulatory and self-measured blood pressure in a study of nitrendipine vs. bisoprolol","volume":"42","author":"Mengden","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jash.2007.08.004_bib27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.amjhyper.2003.09.008","article-title":"Comparison of valsartan and amlodipine on ambulatory and morning blood pressure in hypertensive patients","volume":"17","author":"Eguchi","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2007.08.004_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00126097-200408000-00005","article-title":"Sustained antihypertensive activity of telmisartan compared with valsartan","volume":"9","author":"Lacourci\u00e8re","year":"2004","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.jash.2007.08.004_bib29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.amjhyper.2004.02.016","article-title":"Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period","volume":"17","author":"White","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2007.08.004_bib30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ahj.2005.02.014","article-title":"Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting","volume":"151","author":"White","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jash.2007.08.004_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00126097-200506000-00008","article-title":"Ambulatory blood pressure monitoring in the primary care setting: assessment of therapy on the circadian variation of blood pressure from the MICCAT-2 Trial","volume":"10","author":"White","year":"2005","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.jash.2007.08.004_bib32","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.265.24.3255","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP)","volume":"265","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2007.08.004_bib33","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension","volume":"350","author":"Staessen","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2007.08.004_bib34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/archinte.160.2.149","article-title":"Benefits of antihypertensive therapy in older patients with hypertension","volume":"160","author":"White","year":"2000","journal-title":"Arch Intern Med"}],"container-title":["Journal of the American Society of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171107001714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171107001714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T07:51:19Z","timestamp":1546329079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933171107001714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S1933171107001714"],"URL":"https:\/\/doi.org\/10.1016\/j.jash.2007.08.004","relation":{},"ISSN":["1933-1711"],"issn-type":[{"value":"1933-1711","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}